Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
2.630
+0.030 (1.15%)
Aug 15, 2025, 9:49 AM - Market open
Maravai LifeSciences Holdings (MRVI) Adjusted Ebitda by Segment
History
| Date | Biologics Safety Testing | Nucleic Acid Production |
|---|---|---|
| Mar 31, 2025 | 42.59M | 31.83M |
| Dec 31, 2024 | 43.84M | 50.81M |
| Sep 30, 2024 | 45.90M | 70.85M |
| Jun 30, 2024 | 46.22M | 71.98M |
| Mar 31, 2024 | 47.09M | 64.87M |
| Dec 31, 2023 | 46.91M | 82.66M |
| Sep 30, 2023 | 46.52M | 194.09M |
| Jun 30, 2023 | 48.27M | 311.31M |
| Mar 31, 2023 | 52.06M | 483.41M |
| Dec 31, 2022 | 54.84M | 638.34M |
| Sep 30, 2022 | 55.89M | 666.46M |
| Jun 30, 2022 | 56.49M | 682.99M |
| Mar 31, 2022 | 56.69M | 653.02M |
| Dec 31, 2021 | 54.44M | 565.25M |
| Sep 30, 2021 | 53.13M | 459.39M |
| Jun 30, 2021 | 51.53M | 355.75M |
| Mar 31, 2021 | 46.86M | 210.02M |
| Dec 31, 2020 | 44.52M | 133.82M |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.